BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2017
View Archived Issues
Bristol-Myers Squibb initiates phase I trial of BMS-986235 in healthy subjects
Read More
Roche opens enrollment in phase III trial of polatuzumab vedotin with R-CHP for DLBCL
Read More
Akesobio studies AK-104 in advanced solid tumors
Read More
Regeneron initiates phase II study of REGN-2477 for fibrodysplasia ossificans progressiva
Read More
Phase II/III data presented for fexinidazole in African T. brucei gambiense trypanosomiasis
Read More
Patient enrollment ongoing in phase III study of HD-201 in patients with HER2+ early breast cancer
Read More
Servier Canada enters a new partnership with CQDM
Read More
Theralase reports on new anticancer vaccine
Read More
Initiation of phase I/II study of IMM-529 in patients with Clostridium difficile infection
Read More
First preclinical data presented for AG-10 in ATTR cardiomyopathy
Read More
Etanercept biosimilar LBEC-0101 demonstrates equivalence to original
Read More
Antimalarial SJ-733 safe in first-in-human study
Read More
New PROFYLE program in Canada aims to accelerate research breakthroughs in pediatric cancer
Read More
Imugene raises financing to advance HER-Vaxx development
Read More
Crown Bioscience and DSI collaborate on implantable device to monitor blood glucose in research
Read More
INHALE study of Amikacin Inhale does not meet primary endpoint
Read More
Alzinova advances preclinical work on ALZ-101
Read More
ChAd3-EBO-Z Ebola vaccine well tolerated and immunogenic in children
Read More
Puma Biotechnology and Specialised Therapeutics Asia sign commercialization agreement for Nerlynx
Read More
Esteve describes novel dual voltage-gated calcium channel ligands and NET inhibitors
Read More
New phase I trial explores use of AZD-1775 in head and neck cancer
Read More
New proteinase-activated PAR2 receptor antagonists identified at AstraZeneca
Read More
Boehringer Ingelheim patents semicarbazide-sensitive amine oxidase inhibitors
Read More
AstraZeneca presents novel ataxia telangiectasia mutated kinase inhibitors
Read More
Arvinas and Macroceutics establish multi-target screening collaboration
Read More